BeOne registers two trials: first-in-human BON-107 study and myeloma quadruplet with sonrotoclaxNov 12Weekly roundup, 2 itemsBeiGenesonrotoclax
BeOne Medicines registers Phase 1 trial of BG-T0050 in DLBCL and other B-cell cancersOct 21Weekly roundup, 5 itemsazacitidineBeiGene
BeOne Medicines registers two Phase 1 hepatic impairment PK studies for sonrotoclax and tacabrutidegOct 2Weekly roundup, 2 itemsBeiGenesonrotoclax
Genentech registers Phase I trial of RO7890597 in healthy volunteersSep 2Weekly roundup, 3 itemsBeiGeneobinutuzumab
BeOne Medicines files STAR Market interim report, discloses R&D spend by product under US GAAPAug 26Quarterly updateBeiGene
BeOne registers pediatric trial of sonrotoclax in relapsed AML and B-cell ALLAug 18Trial updateBeiGenesonrotoclax
BeOne Medicines reports Q2 2026 results, raises full-year revenue guidanceAug 5Quarterly updateBeiGenesonrotoclax